Catalyst Wire Dossier Catalyst Wire Dossier

CD-40 autologous tumor cells

CD-40 autologous tumor cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD-40 autologous tumor cells, covering 2012-05-23 to 2012-05-23. Get the full timeline:

Most recent: Clinical Trial Update: Treatment of Chronic Lymphocytic B-Leukemia With IL-2 and CD-40 Autologous Tumor Cells [Phase 1]

See pricing